@article{5abdaec3ae27484793ed68b641f527fb,
title = "Potential of pharmacogenetics in minimizing drug therapy problems in cystic fibrosis",
keywords = "Adverse drug reactions, Cystic fibrosis, Drug therapy problems, Genomics, Pharmacogenomics, Pharmacotherapy, Precision medicine, Humans, Male, Genotype, Pharmacogenetics/methods, Adolescent, Female, Pharmacogenomic Testing/methods, Adult, Retrospective Studies, Child, Cystic Fibrosis/genetics",
author = "Anindit Chhibber and Watanabe, \{Alexandre Hikiji\} and Hollyann Jacobs and Aditi Kharat and Syeed, \{Sakil M.\} and Sherwin, \{Catherine M.\} and Nathorn Chaiyakunapruk and Joseph Biskupiak and Yellepeddi, \{Venkata K.\} and Diana Brixner and Young, \{David C.\}",
note = "Copyright {\textcopyright} 2024 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.",
year = "2024",
month = sep,
doi = "10.1016/j.jcf.2024.06.006",
language = "English",
volume = "23",
pages = "1010--1019",
journal = "Journal of Cystic Fibrosis",
issn = "1569-1993",
number = "5",
}